Fastest Earnings Growth Canadian Stocks — Health Care
Canadian stocks ranked by year-over-year earnings growth.
Updated September 23, 2026130 companiesTotal market cap $1352.8B
Showing 130 companies (CDRs hidden)
| Rank | Company | Symbol | Market Cap | P/E Ratio | Earnings Growth (YoY) |
|---|---|---|---|---|---|
| 1 | Azenta Inc | AZTA:US | $1.5B | - | 8777.80% |
| 2 | Covalon Technologies Ltd. | COV:V | $110M | 24.9 | 4225.30% |
| 3 | Hydreight Technologies Inc | NURS:V | $171M | 24.5 | 3874.60% |
| 4 | Quest PharmaTech Inc | QPT:V | $4M | 0.8 | 3010.20% |
| 5 | Sarepta Therapeutics Inc | SRPT:US | $2.1B | - | 2663.80% |
| 6 | Lifestance Health Group Inc | LFST:US | $4.8B | 97.5 | 1927.50% |
| 7 | DRI Healthcare Trust | DHT-UN:TO | $997M | - | 1521.40% |
| 8 | DRI Healthcare Trust | DHT-U:TO | $686M | - | 1521.40% |
| 9 | BioCryst Pharmaceuticals Inc | BCRX:US | $2.2B | - | 1400.00% |
| 10 | Ligand Pharmaceuticals Incorporated | LGND:US | $5.8B | 29.8 | 825.00% |
| 11 | Amotiv Limited | AOV:TO | $577M | - | 800.00% |
| 12 | Medicure Inc | MPH:V | $28M | - | 709.60% |
| 13 | The Joint Corp | JYNT:US | $120M | 60.6 | 652.60% |
| 14 | Indivior PLC Ordinary Shares | INDV:US | $4.3B | 13.0 | 600.00% |
| 15 | Innoviva Inc | INVA:US | $1.5B | 4.9 | 590.40% |
| 16 | Sotera Health Co | SHC:US | $5.3B | 32.8 | 569.50% |
| 17 | Organogenesis Holdings Inc | ORGO:US | $190M | - | 555.20% |
| 18 | NeuPath Health Inc | NPTH:V | $30M | 26.5 | 537.10% |
| 19 | Oramed Pharmaceuticals Inc | ORMP:US | $198M | 1.2 | 493.50% |
| 20 | Sol Gel Technologies Ltd | SLGL:US | $200M | - | 487.60% |
| 21 | Varex Imaging Corp | VREX:US | $778M | 34.8 | 453.40% |
| 22 | Sensus Healthcare Inc | SRTS:US | $51M | - | 433.30% |
| 23 | Creative Medical Technology Holdings Inc | CELZ:US | $7M | - | 358.90% |
| 24 | The Cooper Companies, Inc | COO:US | $10.5B | 19.0 | 357.10% |
| 25 | Sinovac Biotech Ltd | SVA:US | $642M | 6.7 | 354.80% |
| 26 | Protagonist Therapeutics Inc | PTGX:US | $9.4B | 140.8 | 351.30% |
| 27 | SBC Medical Group Holdings Incorporated | SBC:US | $518M | 10.5 | 338.90% |
| 28 | Omnicell Inc | OMCL:US | $1.5B | 38.6 | 333.30% |
| 29 | Daxor Corporation | DXR:US | $66M | 6.6 | 329.30% |
| 30 | Insulet Corporation | PODD:US | $9.7B | 26.2 | 328.60% |
| 31 | Bioventus Inc | BVS:US | $909M | 17.1 | 327.30% |
| 32 | Sucro Limited | SUGR:V | $228M | 4.1 | 325.00% |
| 33 | Veracyte Inc | VCYT:US | $3.5B | 31.0 | 288.90% |
| 34 | LivaNova PLC | LIVN:US | $4.3B | 23.1 | 287.80% |
| 35 | Atea Pharmaceuticals Inc | AVIR:US | $436M | - | 264.10% |
| 36 | Medline Inc. Class A Common Stock | MDLN:US | $43.0B | 40.0 | 262.00% |
| 37 | ImmuCell Corporation | ICCC:US | $91M | 142.7 | 259.90% |
| 38 | Privia Health Group Inc | PRVA:US | $2.5B | 88.8 | 250.00% |
| 39 | Airsculpt Technologies Inc | AIRS:US | $175M | - | 200.00% |
| 40 | BrightSpring Health Services, Inc. Common Stock | BTSG:US | $11.2B | 50.5 | 196.60% |
| 41 | ANI Pharmaceuticals Inc | ANIP:US | $1.8B | 17.0 | 191.10% |
| 42 | CardioComm Solutions Inc. | EKG:V | $2M | 0.0 | 188.50% |
| 43 | BeiGene, Ltd. | ONC:US | $41.6B | 65.8 | 166.70% |
| 44 | Gyre Therapeutics Inc. | GYRE:US | $794M | - | 166.20% |
| 45 | WELL Health Technologies Corp | WELL:TO | $1.1B | 220.5 | 158.90% |
| 46 | Amneal Pharmaceuticals, Inc. Class A Common Stock | AMRX:US | $6.8B | 40.6 | 157.10% |
| 47 | Decibel Cannabis Company Inc | DB:V | $60M | - | 154.00% |
| 48 | Immunocore Holdings Ltd | IMCR:US | $1.7B | - | 150.00% |
| 49 | Tactile Systems Technology Inc | TCMD:US | $518M | 21.4 | 144.10% |
| 50 | Pro-Dex Inc | PDEX:US | $232M | 17.6 | 143.40% |
| 51 | Alignment Healthcare LLC | ALHC:US | $1.7B | 43.8 | 142.90% |
| 52 | NexgenRX Inc. | NXG:V | $43M | 20.0 | 140.00% |
| 53 | NeoGenomics Inc | NEO:US | $2.4B | - | 130.60% |
| 54 | Bio-Techne Corp | TECH:US | $11.4B | 62.5 | 128.60% |
| 55 | Cronos Group Inc | CRON:TO | $1.8B | 17.9 | 126.80% |
| 56 | Cronos Group Inc | CRON:US | $1.3B | 18.1 | 126.80% |
| 57 | Ironwood Pharmaceuticals Inc | IRWD:US | $729M | 5.6 | 125.70% |
| 58 | Astrana Health Inc | ASTH:US | $1.7B | 42.8 | 110.50% |
| 59 | MiMedx Group Inc | MDXG:US | $702M | 120.3 | 99.50% |
| 60 | Nutex Health Inc | NUTX:US | $1.4B | 7.8 | 95.90% |
| 61 | argenx NV ADR | ARGX:US | $61.5B | 37.6 | 95.20% |
| 62 | Sienna Senior Living Inc | SIA:TO | $2.3B | 38.4 | 93.20% |
| 63 | Harmony Biosciences Holdings | HRMY:US | $2.4B | 13.6 | 88.20% |
| 64 | Inogen Inc | INGN:US | $139M | - | 87.30% |
| 65 | Progyny Inc | PGNY:US | $2.0B | 28.5 | 78.90% |
| 66 | Aurinia Pharmaceuticals Inc | AUPH:US | $2.2B | 7.3 | 75.50% |
| 67 | Spero Therapeutics Inc | SPRO:US | $66M | 8.1 | 75.30% |
| 68 | Cytek Biosciences Inc | CTKB:US | $686M | - | 73.50% |
| 69 | Bausch Health Companies Inc | BHC:TO | $3.1B | - | 70.40% |
| 70 | Amgen Inc | AMGN:US | $212.6B | 24.5 | 64.90% |
| 71 | Brainsway Ltd | BWAY:US | $548M | 59.3 | 64.60% |
| 72 | Clene Inc. | CLNN:US | $65M | - | 61.40% |
| 73 | CytomX Therapeutics Inc | CTMX:US | $601M | - | 60.60% |
| 74 | Vir Biotechnology Inc | VIR:US | $1.8B | - | 58.50% |
| 75 | Gilead Sciences Inc | GILD:US | $186.7B | - | 54.80% |
| 76 | Simulations Plus Inc | SLP:US | $373M | 46.1 | 46.70% |
| 77 | Abcellera Biologics Inc | ABCL:US | $4.1B | - | 45.90% |
| 78 | DexCom Inc | DXCM:US | $33.8B | 35.4 | 43.60% |
| 79 | Halozyme Therapeutics Inc | HALO:US | $12.6B | 32.7 | 42.90% |
| 80 | Premier Health of America Inc | PHA:V | $0M | - | 39.80% |
| 81 | Biosyent Inc. | RX:V | $181M | 18.8 | 39.20% |
| 82 | Krystal Biotech Inc | KRYS:US | $9.9B | 41.9 | 38.80% |
| 83 | Aveanna Healthcare Holdings Inc | AVAH:US | $2.9B | 10.7 | 38.50% |
| 84 | Incyte Corporation | INCY:US | $25.3B | 15.9 | 37.70% |
| 85 | Medpace Holdings Inc | MEDP:US | $17.4B | 36.7 | 37.10% |
| 86 | Puma Biotechnology Inc | PBYI:US | $507M | 19.3 | 35.80% |
| 87 | Grifols SA ADR | GRFS:US | $5.0B | 9.7 | 32.90% |
| 88 | Neurocrine Biosciences Inc | NBIX:US | $14.5B | 20.8 | 31.10% |
| 89 | Co-Diagnostics, Inc. Common Stock | CODX:US | $7M | - | 30.80% |
| 90 | Kiniksa Pharmaceuticals Ltd | KNSA:US | $6.1B | 78.8 | 30.40% |
| 91 | OraSure Technologies Inc | OSUR:US | $275M | - | 29.60% |
| 92 | Crescita Therapeutics Inc | CTX:TO | $15M | - | 28.70% |
| 93 | HealthStream Inc | HSTM:US | $890M | 40.4 | 28.40% |
| 94 | Medirom Healthcare Technologies Inc | MRM:US | $6M | 2.0 | 27.80% |
| 95 | Intuitive Surgical Inc | ISRG:US | $143.9B | 46.0 | 26.50% |
| 96 | Exelixis Inc | EXEL:US | $14.4B | 18.3 | 26.20% |
| 97 | Pennant Group Inc | PNTG:US | $1.4B | 43.3 | 25.00% |
| 98 | Phibro Animal Health Corporation | PAHC:US | $1.4B | 14.5 | 24.60% |
| 99 | Addus HomeCare Corporation | ADUS:US | $2.1B | 20.0 | 24.20% |
| 100 | Corcept Therapeutics Incorporated | CORT:US | $12.7B | 255.4 | 24.10% |
| 101 | Kamada | KMDA:US | $512M | 23.3 | 23.10% |
| 102 | LeMaitre Vascular Inc | LMAT:US | $1.9B | 28.3 | 22.60% |
| 103 | UFP Technologies Inc | UFPT:US | $2.2B | 30.9 | 21.30% |
| 104 | CorVel Corp | CRVL:US | $3.7B | 32.7 | 21.20% |
| 105 | Merit Medical Systems Inc | MMSI:US | $5.2B | 35.9 | 20.40% |
| 106 | Vericel Corp Ord | VCEL:US | $2.0B | 82.4 | 18.90% |
| 107 | IDEXX Laboratories Inc | IDXX:US | $40.6B | 36.2 | 17.60% |
| 108 | Henry Schein Inc | HSIC:US | $9.5B | 24.8 | 17.10% |
| 109 | GE HealthCare Technologies Inc. | GEHC:US | $29.9B | 15.3 | 16.80% |
| 110 | The Ensign Group Inc | ENSG:US | $10.3B | 27.6 | 16.70% |
| 111 | Waystar Holding Corp. Common Stock | WAY:US | $4.9B | 36.6 | 16.70% |
| 112 | Dentsply Sirona Inc | XRAY:US | $1.9B | - | 15.20% |
| 113 | HealthEquity Inc | HQY:US | $7.8B | 34.1 | 14.70% |
| 114 | ADMA Biologics Inc | ADMA:US | $2.2B | 14.0 | 14.30% |
| 115 | United Therapeutics Corporation | UTHR:US | $21.3B | 17.8 | 13.40% |
| 116 | ACADIA Pharmaceuticals Inc | ACAD:US | $4.6B | 11.8 | 13.30% |
| 117 | Option Care Health Inc | OPCH:US | $3.6B | 18.1 | 12.90% |
| 118 | rYojbaba Co., Ltd. Common Shares | RYOJ:US | $46M | 399.0 | 11.80% |
| 119 | Supernus Pharmaceuticals Inc | SUPN:US | $2.5B | - | 11.10% |
| 120 | Arrowhead Pharmaceuticals Inc | ARWR:US | $10.2B | - | 9.80% |
| 121 | DocGo Inc | DCGO:US | $36M | - | 9.00% |
| 122 | Agilent Technologies Inc | A:US | $43.3B | 29.7 | 8.50% |
| 123 | Vertex Pharmaceuticals Inc | VRTX:US | $130.4B | 30.0 | 8.00% |
| 124 | Medexus Pharmaceuticals Inc | MDP:TO | $160M | - | 6.80% |
| 125 | CorMedix Inc | CRMD:US | $606M | 3.6 | 6.70% |
| 126 | Adapthealth Corp | AHCO:US | $785M | - | 6.70% |
| 127 | Amphastar P | AMPH:US | $1.0B | 14.5 | 4.70% |
| 128 | Jazz Pharmaceuticals PLC | JAZZ:US | $15.6B | 16.5 | 3.20% |
| 129 | Anbio Biotechnology Class A Ordinary Shares | NNNN:US | $245M | 37.2 | 2.80% |
| 130 | Integra LifeSciences Holdings | IART:US | $1.2B | - | 0.40% |
Advertisement
Frequently Asked Questions
Which Canadian company ranks #1 by earnings growth (yoy) in Health Care?
As of September 23, 2026, Azenta Inc (AZTA:US) ranks #1 in Health Care at 8777.80%.
How often is this ranking updated?
The table is rebuilt from live fundamentals throughout the day. This page currently shows data as of September 23, 2026.
How many companies are in this earnings growth (yoy) list?
This view shows 130 Canadian listings in Health Care. Canadian Depositary Receipts are hidden by default.
What is the difference between TSX and TSXV?
The Toronto Stock Exchange (TSX) lists larger established companies. The TSX Venture Exchange (TSXV) lists earlier-stage companies. Use the exchange filter to separate them.
Explore More Stock Rankings
Largest by Market Cap
Companies with the highest market capitalization
Largest by Revenue
Companies with the highest annual revenue
Highest Profit Margin
Most profitable companies by net margin
Highest Return on Equity
Companies generating the best returns for shareholders
Highest Return on Assets
Most efficient companies at using assets
Highest Dividend Yield
Top dividend-paying stocks
Fastest Revenue Growth
Companies with strongest year-over-year revenue growth